Konstantin Baranov

Konstantin Baranov

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EMElena Makarova
Elena Makarova
AKAntonina Kazantseva
Antonina Kazantseva
ADAnastasia Dubinina
Anastasia Dubinina
TJTatiana Jakovleva
Tatiana Jakovleva
NBNatalia Balybina
Natalia Balybina
NBNadezhda Bazhan
Nadezhda Bazhan
The preference for high-calorie foods depends on sex and contributes to obesity development. Fibroblast growth factor 21 (FGF21) beneficially affects taste preferences and obesity, but its action has mainly been studied in males. The aim of this study was to compare the effects of FGF21 on food preferences and glucose and lipid metabolism in C57Bl/6J male and female mice with diet-induced obesity. Mice were injected with FGF21 or vehicle for 7 days. Body weight, choice between standard (SD) and high-fat (HFD) diets, blood parameters, and gene expression in white (WAT) and brown (BAT) adipose tissues, liver, muscles, and the hypothalamus were assessed. Compared to males, females had a greater preference for HFD; less WAT; lower levels of cholesterol, glucose, and insulin; and higher expression of Fgf21, Insr, Ppara, Pgc1, Acca and Accb in the liver and Dio2 in BAT. FGF21 administration decreased adiposity; blood levels of cholesterol, glucose, and insulin; hypothalamic Agrp expression, increased SD intake, decreased HFD intake independently of sex, and increased WAT expression of Pparg, Lpl and Lipe only in females. Thus, FGF21 administration beneficially affected mice of both sexes despite obesity-associated sex differences in metabolic characteristics, and it induced female-specific activation of gene expression in WAT.

Verified
Journal Article
Open access
PDF file
MBMariya Borgoyakova
Mariya Borgoyakova
LKLarisa I. Karpenko
Larisa I. Karpenko
ARAndrey P. Rudometov
Andrey P. Rudometov
EVEkaterina A. Volosnikova
Ekaterina A. Volosnikova
IMIuliia Merkuleva
Iuliia Merkuleva
AIAlexander Ilyichev
Alexander Ilyichev
Despite the fact that a range of vaccines against COVID-19 have already been created and are used for mass vaccination, the development of effective, safe, technological, and affordable vaccines continues. We have designed a vaccine that combines the recombinant protein and DNA vaccine approaches in a self-assembled particle. The receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 was conjugated to polyglucin:spermidine and mixed with DNA vaccine (pVAXrbd), which led to the formation of particles of combined coronavirus vaccine (CCV-RBD) that contain the DNA vaccine inside and RBD protein on the surface. CCV-RBD particles were characterized with gel filtration, electron microscopy, and biolayer interferometry. To investigate the immunogenicity of the combined vaccine and its components, mice were immunized with the DNA vaccine pVAXrbd or RBD protein as well as CCV-RBD particles. The highest antigen-specific IgG and neutralizing activity were induced by CCV-RBD, and the level of antibodies induced by DNA or RBD alone was significantly lower. The cellular immune response was detected only in the case of DNA or CCV-RBD vaccination. These results demonstrate that a combination of DNA vaccine and RBD protein in one construct synergistically increases the humoral response to RBD protein in mice.

19 January 2018 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Closed access
PDF file
EREvdokiya Reshetnikova
Evdokiya Reshetnikova
SGSergey Guselnikov
Sergey Guselnikov
OVOlga Volkova
Olga Volkova
KBKonstantin Baranov
Konstantin Baranov
ATAlexander V Taranin
Alexander V Taranin
LMLudmila Mechetina
Ludmila Mechetina

22 September 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
DSDmitriy Smagin
Dmitriy Smagin
IKIrina Kovalenko
Irina Kovalenko
AGAnna G. Galyamina
Anna G. Galyamina
IBIrina Belozertseva
Irina Belozertseva
NTNikolay V. Tamkovich
Nikolay V. Tamkovich
NKNatalia N. Kudryavtseva
Natalia N. Kudryavtseva
There is experimental evidence that chronic social defeat stress is accompanied by the development of an anxiety, development of a depression-like state, and downregulation of serotonergic genes in midbrain raphe nuclei of male mice. Our study was aimed at investigating the effects of chronic lithium chloride (LiCl) administration on anxiety behavior and the expression of serotonergic genes in midbrain raphe nuclei of the affected mice. A pronounced anxiety-like state in male mice was induced by chronic social defeat stress in daily agonistic interactions. After 6 days of this stress, defeated mice were chronically treated with saline or LiCl (100 mg/kg, i.p., 2 weeks) during the continuing agonistic interactions. Anxiety was assessed by behavioral tests. RT-PCR was used to determine Tph2, Htr1a, Htr5b, and Slc6a4 mRNA expression. The results revealed anxiolytic-like effects of LiCl on social communication in the partition test and anxiogenic-like effects in both elevated plus-maze and social interaction tests. Chronic LiCl treatment upregulated serotonergic genes in midbrain raphe nuclei. Thus, LiCl effects depend on the treatment mode, psycho-emotional state of the animal, and experimental context (tests). It is assumed that increased expression of serotonergic genes is accompanied by serotonergic system activation and, as a side effect, by higher anxiety.

7 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
EMElena Makarova
Elena Makarova
AKAntonina Kazantseva
Antonina Kazantseva
ADAnastasia Dubinina
Anastasia Dubinina
EDElena Denisova
Elena Denisova
TJTatiana Jakovleva
Tatiana Jakovleva
NBNadezhda Bazhan
Nadezhda Bazhan
FGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the Ay mutation that evokes melanocortin receptor 4 blockade, obesity, and hepatosteatosis. This suggests that the ability of FGF21 to correct melanocortin obesity may depend on sex. This study compares FGF21 action on food intake, locomotor activity, gene expression, metabolic characteristics, and liver state in obese Ay males and females. Ay mice were administered FGF21 for seven days, and metabolic parameters and gene expression in different tissues were assessed. Placebo-treated females were more obese than males and had lower levels of blood insulin and liver triglycerides, and higher expression of genes for insulin signaling in the liver, white adipose tissue (WAT) and muscles, and pro-inflammatory cytokines in the liver. FGF21 administration did not affect body weight, and increased food intake, locomotor activity, expression of Fgf21 and Ucp1 in brown fat and genes related to lipolysis and insulin action in WAT regardless of sex; however, it decreased hyperinsulinemia and hepatic lipid accumulation and increased muscle expression of Cpt1 and Irs1 only in males. Thus, FGF21’s beneficial effects on metabolic disorders associated with melanocortin obesity are more pronounced in males.

4 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDmitriy Smagin
Dmitriy Smagin
IKIrina Kovalenko
Irina Kovalenko
AGAnna G. Galyamina
Anna G. Galyamina
IBIrina Belozertseva
Irina Belozertseva
NTNikolay V. Tamkovich
Nikolay V. Tamkovich
NKNatalia N. Kudryavtseva
Natalia N. Kudryavtseva
There are experimental data that mixed anxiety/depression-like state induced by chronic social defeat stress is accompanied by development of anxiety and downregulation of serotonergic gene expression in the midbrain raphe nuclei of male mice. The paper aimed to study the effect of chronic lithium chloride (LiCl) on anxious behaviors and the expression of serotonergic genes ( Tph2 , Slc6a4 , Htr1a , Htr5b ) in the midbrain raphe nuclei of defeated mice. Slight anxiolytic effects of LiCl were found on the commucativeness in the partition test, and anxiogenic-like effects, estimated by the elevated plus-maze and social interactions tests. Chronic LiCl treatment induced overexpression of the serotonergic genes in the midbrain raphe nuclei of defeated mice. We can assume that effects of LiCl, rather anxiogenic, may be due to activation of serotonergic system induced by hyperexpression of serotonergic genes. Our findings will allow to understand the factors involved in the positive and side effects of lithium on anxiety and function of serotonergic genes which are involved into mechanisms of depression.